Mapk1-flox Mouse
Common Name
Mapk1-flox
제품 ID
S-CKO-09574
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-26413-Mapk1-B6J-VA
상태
이 마우스 계통을 논문에서 사용할 경우, “Mapk1-flox Mouse (카탈로그 번호 S-CKO-09574)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Mapk1-flox
품종 계통계통 ID
CKOCMP-26413-Mapk1-B6J-VA
유전자명
제품 ID
S-CKO-09574
유전자 별칭
ERK, Erk2, MAPK2, PRKM2, Prkm1, p41mapk, p42mapk, 9030612K14Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 16
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000069107
NCBI 전사체 ID
NM_011949
타겟 영역
Exon 3
유효 영역 크기
~1.7 kb
유전자 연구 개요
Mapk1, also known as mitogen-activated protein kinase 1, is a key component of the MAP kinase signal transduction pathway. It has functions both as a kinase, phosphorylating histones, and as a transcription factor, directly binding to gene promoter regions to regulate gene expression. This dual-role protein is involved in multiple biological processes and is crucial for cell survival, proliferation, and response to various stimuli [2].
In breast cancer, phosphorylation of ULK1 by MAPK1/ERK2-MAPK3/ERK1 kinase triggers ULK1's interaction with BTRC, leading to its K48-linked ubiquitination and proteasome degradation. ULK1 deficiency, due to MAPK1-mediated degradation, attenuates mitophagy, activates the NLRP3 inflammasome, and promotes breast cancer bone metastasis [1].
In gastric cancer, MAPK1 promotes cell invasion and migration by bidirectionally regulating target genes as a transcription factor [2].
In diabetic kidney disease, high glucose increases MAPK1, which reduces PACS-2 levels, disrupts the mitochondria-associated endoplasmic reticulum membrane (MAM), and causes mitochondrial fragmentation. Inhibition of MAPK1 in diabetic mice increases PACS-2 and protects against MAM loss and mitochondrial fragmentation [3].
In pancreatic cancer, SOX4 promotes the phosphorylation modification of IQGAP1 by activating MAPK1 transcription, facilitating pancreatic cancer growth and metastasis [4].
In bladder cancer, circPSMA7 acts as a sponge for miR-128-3p, increasing MAPK1 expression and promoting cancer progression [5].
In prostate cancer, miR-92a-1-5p enriched extracellular vesicles regulate osteoclast function via reduction of MAPK1 [6].
In osteosarcoma, circ_0020378 promotes cell proliferation and migration by regulating the miR-556-5p/MAPK1 axis [7].
In cervical cancer, LINC00511 promotes cancer progression by regulating the miR-497-5p/MAPK1 axis [8].
In Leishmania donovani, MAPK1 modulates the expression levels of various phosphoproteins involved in metabolism, signal transduction, etc., which are crucial for parasite survival, infectivity, etc. [9].
In glioblastoma, SNHG12 sponges miR-129-5p, leading to upregulation of MAPK1 and endowing cells with temozolomide resistance [10].
In conclusion, Mapk1 plays diverse and crucial roles in multiple biological processes and disease conditions. Through gene-knockout or conditional-knockout mouse models and other functional studies, it has been revealed that Mapk1 is involved in cancer metastasis, cell invasion, mitochondrial function in diabetes-related diseases, and parasite survival. Understanding the functions of Mapk1 provides insights into disease mechanisms and potential therapeutic targets for various diseases such as cancer and diabetic kidney disease.
References:
1. Deng, Rong, Zhang, Hai-Liang, Huang, Jun-Hao, Tang, Jun, Zhu, Xiao-Feng. 2020. MAPK1/3 kinase-dependent ULK1 degradation attenuates mitophagy and promotes breast cancer bone metastasis. In Autophagy, 17, 3011-3029. doi:10.1080/15548627.2020.1850609. https://pubmed.ncbi.nlm.nih.gov/33213267/
2. Wang, Yue, Guo, Zheng, Tian, Yueli, Li, Xingang, Song, Ying. 2023. MAPK1 promotes the metastasis and invasion of gastric cancer as a bidirectional transcription factor. In BMC cancer, 23, 959. doi:10.1186/s12885-023-11480-3. https://pubmed.ncbi.nlm.nih.gov/37817112/
3. Liu, Shanshan, Han, Shuai, Wang, Cuili, Chen, Jianghua, Jiang, Hong. 2024. MAPK1 Mediates MAM Disruption and Mitochondrial Dysfunction in Diabetic Kidney Disease via the PACS-2-Dependent Mechanism. In International journal of biological sciences, 20, 569-584. doi:10.7150/ijbs.89291. https://pubmed.ncbi.nlm.nih.gov/38169625/
4. Song, Chao, Wang, Ganggang, Liu, Mengmeng, Xu, Yaolin, Liu, Liang. 2024. Deciphering the SOX4/MAPK1 regulatory axis: a phosphoproteomic insight into IQGAP1 phosphorylation and pancreatic Cancer progression. In Journal of translational medicine, 22, 602. doi:10.1186/s12967-024-05377-3. https://pubmed.ncbi.nlm.nih.gov/38943117/
5. Yi, Jiahe, Ma, Xueyou, Ying, Yufan, Li, Jiangfeng, Xie, Liping. 2024. N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128-3p/MAPK1 axis. In Cancer letters, 585, 216613. doi:10.1016/j.canlet.2024.216613. https://pubmed.ncbi.nlm.nih.gov/38211649/
6. Yu, Lijuan, Sui, Bingdong, Zhang, Xin, Hao, Xiaoke, Zheng, Lei. 2023. miR-92a-1-5p enriched prostate cancer extracellular vesicles regulate osteoclast function via MAPK1 and FoxO1. In Journal of experimental & clinical cancer research : CR, 42, 109. doi:10.1186/s13046-023-02685-2. https://pubmed.ncbi.nlm.nih.gov/37131239/
7. Li, Zi, Zheng, Lei, Yang, Liang, Yan, Xiongwei, Pu, Jian. 2022. Hsa_circ_0020378 targets miR-556-5p/MAPK1 to regulate osteosarcoma cell proliferation and migration. In Gene, 856, 147135. doi:10.1016/j.gene.2022.147135. https://pubmed.ncbi.nlm.nih.gov/36572073/
8. Lu, Mingming, Gao, Qing, Wang, Yafei, Ren, Jie, Zhang, Tingting. 2022. LINC00511 promotes cervical cancer progression by regulating the miR-497-5p/MAPK1 axis. In Apoptosis : an international journal on programmed cell death, 27, 800-811. doi:10.1007/s10495-022-01768-3. https://pubmed.ncbi.nlm.nih.gov/36103025/
9. Kaur, Pavneet, Anand, Apeksha, Bhat, Adil, Maras, Jaswinder Singh, Goyal, Neena. 2021. Comparative phosphoproteomic analysis unravels MAPK1 regulated phosphoproteins in Leishmania donovani. In Journal of proteomics, 240, 104189. doi:10.1016/j.jprot.2021.104189. https://pubmed.ncbi.nlm.nih.gov/33757882/
10. Lu, Chenfei, Wei, Yutian, Wang, Xiefeng, Yan, Wei, You, Yongping. 2020. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. In Molecular cancer, 19, 28. doi:10.1186/s12943-020-1137-5. https://pubmed.ncbi.nlm.nih.gov/32039732/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
